CabañasR, RamírezE, SendagortaE, et al.Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol, 2020; 30(4):229–253. doi: 10.18176/jiaci.0480.
2.
Do-PhamG, CharachonA, DuongTA, et al.Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases: correspondence. Br J Dermatol, 2011; 165(1):207–209. doi: 10.1111/j.1365-2133.2011.10293.x.
3.
ChungWL, TeoL, WangYS, et al.Drug hypersensitivity syndrome with significant gastrointestinal involvement. Singapore Med J, 2012; 53(11):e231–e232.
4.
RamírezA, AbrilJC, CanoJ.DRESS syndrome due to antibiotic therapy of osteoarticular infections in children: two case reports. Rev Esp Cir Ortopédica Traumatol Engl Ed, 2015; 59(5):360–364. doi: 10.1016/j.recote.2014.05.007.
5.
SoriaA, BernierC, VeyracG, et al.Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study. J Am Acad Dermatol, 2020; 82(3):606–611. doi: 10.1016/j.jaad.2019.09.036.
6.
ShioharaT, MizukawaY.Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int, 2019; 68(3):301–308. doi: 10.1016/j.alit.2019.03.006.